SEC Form 4 · accession 0001547522-15-000176
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Cox
Director
Period of report
Nov 4, 2015
Accepted (ET)
Nov 9, 2015 · 8:29 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Nov 4, 2015 | J | 55,555 | $0.25 | A | 67,555 | D | |
| Common stock | holding | — | — | — | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued pursuant to agreement for Board service.